Prescription items are NON-RETURNABLE and NON REFUNDABLE Droncit Injectable Veterinarians prescribe Droncit to treat tapeworms and internal parasites in dogs and cats. Just one dose of Droncit effectively treats pets. Treats tapeworms in dogs and cats Convenient single dose treatment Treats several species of tapeworms including those carried by fleas Active ingredient: praziquantel Dogs and cats can get tapeworms from flea bites, eating an infected flea, or by eating infected rodents. If your dog or cat is diagnosed with tapeworm, your veterinarian may prescribe Droncit a fast, effective dewormer. The active ingredient in Droncit tablets is an FDA-approved medicine called praziquantel. This medication works by breaking down the parasite’s skin and stopping it from attaching to the animal’s intestines. The tapeworm then denigrates and is eliminated from the body. Droncit is a convenient treatment -- just one dose of Droncit is enough to treat most pets with tapeworm. DIRECTIONS: Droncit (praziquantel) Injectable Cestocide may be administered by either the subcutaneous or intramuscular route to dogs and cats. The recommended dosage of praziquantel varies according to body weight. Smaller animals require a relatively larger dosage. The optimum dosage for each individual animal will be achieved by utilizing the following dosage schedule. Dogs and Puppies* Dosage Amount 5 lbs. and Under 0.3 ml 6-10 lbs 0.5 ml 11-25 lbs 1 ml Over 25 lbs 0.2 ml/5 lbs Body Weight to a maximum of 3 ml *Not intended for use in puppies less than 4 weeks of age. Cats and Kittens* Dosage Amount 5 lbs. and Under 0.2 ml 5-10 lbs 0.4 ml 11 and Over 0.6 ml maximum *Not intended for use in kittens less than 6 weeks of age. FASTING: The recommended dosage of praziquantel is not affected by the presence or absence of food in the gastrointestinal tract, therefore, FASTING IS NEITHER NECESSARY NOR RECOMMENDED. Administration Droncit (praziquantel) Injectable Cestocide may be administered by either the subcutaneous or intramuscular route to dogs and cats. The intramuscular route may be preferred in dogs due to a brief period of pain that occasionally follows subcutaneous administration. Anaphylactoid reactions were not observed in clinical trials. However, as with any drug an anaphylactoid reaction can occur with this product and should be treated symptomatically if it occurs. RETREATMENT: For those animals living where reinfections are likely to occur, clients should be instructed in the steps to optimize prevention, otherwise, retreatment may be necessary. This is true in cases of Dipylidium caninum where reinfection is almost certain to occur if fleas are not removed from the animal and its environment. In addition, for control of Echinococcus multilocularis, a program of regular treatment every 21 to 26 days may be indicate
Related
Related